Mechanisms of Epstein-Barr virus nuclear antigen 1 favor Tregs accumulation in nasopharyngeal carcinoma. 2020

Jie Wang, and Yunfan Luo, and Pei Bi, and Juan Lu, and Fan Wang, and Xiong Liu, and Bao Zhang, and Xiangping Li
Department of Otolaryngology, Head and Neck Surgery, Nanfang Hospital, Southern Medical University, Guangzhou, China.

Documented reports proved that Epstein-Barr virus (EBV) infection increased infiltration of Tregs in malignancy. However, the mechanism of EBV recruitment Tregs into nasopharyngeal carcinoma (NPC) tissues has not been detailed discussion. Expression of EBV nuclear antigen 1 (EBNA1) and Foxp3 in NPC tissue samples was detected by immunohistochemistry. EBNA1+ NPC cell lines were used to coculture with PBMC, naïve T cells, Tregs, and monocytes. Percent of Treg was detected by flow cytometry. EBNA1 protein was overexpressed in NPC tissues, and was associated with a number of infiltrated Tregs. EBNA1+ NPC cells converted naïve T cells into Tregs by up-regulated TGF-β1. Enhanced CCL20 production in EBNA1-expressed tumor cells increased Tregs migration. Polarized-M2 macrophages by EBNA1 expression cells converted naïve T cells into Tregs. EBNA1 favors accumulation of Tregs in NPC through: (a) upregulated TGF-β1 converted naïve T cell into Treg; (b) upregulated CCL20 increased Treg migration; and (c) polarized-M2 macrophage converted naïve T cell into Treg.

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000077274 Nasopharyngeal Carcinoma A carcinoma that originates in the EPITHELIUM of the NASOPHARYNX and includes four subtypes: keratinizing squamous cell, non-keratinizing, basaloid squamous cell, and PAPILLARY ADENOCARCINOMA. It is most prevalent in Southeast Asian populations and is associated with EPSTEIN-BARR VIRUS INFECTIONS. Somatic mutations associated with this cancer have been identified in NPCR, BAP1, UBAP1, ERBB2, ERBB3, MLL2, PIK3CA, KRAS, NRAS, and ARID1A genes. Carcinoma, Nasopharyngeal,Carcinomas, Nasopharyngeal,Nasopharyngeal Carcinomas
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D045744 Cell Line, Tumor A cell line derived from cultured tumor cells. Tumor Cell Line,Cell Lines, Tumor,Line, Tumor Cell,Lines, Tumor Cell,Tumor Cell Lines
D049109 Cell Proliferation All of the processes involved in increasing CELL NUMBER including CELL DIVISION. Cell Growth in Number,Cellular Proliferation,Cell Multiplication,Cell Number Growth,Growth, Cell Number,Multiplication, Cell,Number Growth, Cell,Proliferation, Cell,Proliferation, Cellular
D019309 Epstein-Barr Virus Nuclear Antigens Nuclear antigens encoded by VIRAL GENES found in HUMAN HERPESVIRUS 4. At least six nuclear antigens have been identified. EBV Nuclear Antigen,EBV Nuclear Antigens,Epstein-Barr Virus Nuclear Antigen,Herpesvirus 4, Human Nuclear Antigens,Nuclear Antigens, Herpesvirus 4, Human,Antigen, EBV Nuclear,Epstein Barr Virus Nuclear Antigen,Epstein Barr Virus Nuclear Antigens,Nuclear Antigen, EBV,Nuclear Antigens, EBV

Related Publications

Jie Wang, and Yunfan Luo, and Pei Bi, and Juan Lu, and Fan Wang, and Xiong Liu, and Bao Zhang, and Xiangping Li
November 1982, International journal of cancer,
Jie Wang, and Yunfan Luo, and Pei Bi, and Juan Lu, and Fan Wang, and Xiong Liu, and Bao Zhang, and Xiangping Li
October 2011, Journal of virology,
Jie Wang, and Yunfan Luo, and Pei Bi, and Juan Lu, and Fan Wang, and Xiong Liu, and Bao Zhang, and Xiangping Li
February 1978, Gan,
Jie Wang, and Yunfan Luo, and Pei Bi, and Juan Lu, and Fan Wang, and Xiong Liu, and Bao Zhang, and Xiangping Li
January 1984, The Annals of otology, rhinology, and laryngology,
Jie Wang, and Yunfan Luo, and Pei Bi, and Juan Lu, and Fan Wang, and Xiong Liu, and Bao Zhang, and Xiangping Li
August 2017, Oncology letters,
Jie Wang, and Yunfan Luo, and Pei Bi, and Juan Lu, and Fan Wang, and Xiong Liu, and Bao Zhang, and Xiangping Li
July 2004, Cancer letters,
Jie Wang, and Yunfan Luo, and Pei Bi, and Juan Lu, and Fan Wang, and Xiong Liu, and Bao Zhang, and Xiangping Li
April 2009, Clinical and vaccine immunology : CVI,
Jie Wang, and Yunfan Luo, and Pei Bi, and Juan Lu, and Fan Wang, and Xiong Liu, and Bao Zhang, and Xiangping Li
February 2014, Cancer,
Jie Wang, and Yunfan Luo, and Pei Bi, and Juan Lu, and Fan Wang, and Xiong Liu, and Bao Zhang, and Xiangping Li
October 2008, PLoS pathogens,
Jie Wang, and Yunfan Luo, and Pei Bi, and Juan Lu, and Fan Wang, and Xiong Liu, and Bao Zhang, and Xiangping Li
December 1977, Lancet (London, England),
Copied contents to your clipboard!